Mesoblast Retires Debt With Lower Cost, 5-Year Credit Line
Mesoblast has refinanced its balance sheet with a new five-year, insider-backed credit facility of up to $125 million, drawing...
Breakthrough: First Wegovy Pill Approved for Weight Loss
FDA has approved the once-daily Wegovy pill (oral semaglutide 25 mg) to reduce excess body weight, maintain weight reduction...
Celularity Reaches Agreements for Strategic Vision Financing
Celularity has secured up to $12 million in new financing through two binding term sheets with a single accredited...
INVO Fertility Aligns Leadership for Surging Growth Strategy
INVO Fertility has restructured its leadership to accelerate a clinic-led growth strategy, appointing Terah Krigsvold as chief financial officer...
Xoma and Takeda Ink Improved Royalty Agreement for Mezagitamab
XOMA Royalty Corporation has amended its long-standing collaboration with Takeda, returning a majority of its royalty interest in mezagitamab...
Mesoblast’s Strong Financial Move: Retires Senior Debt
Mesoblast has refinanced its balance sheet with a new five-year, interest-only credit facility at a fixed 8% rate, drawing...
BiomX Announces Important $3.0 Million Private Placement
BiomX has secured a $3 million private placement anchored by Series Y convertible preferred stock and five-year warrants, a...
Tonix Announces Pricing for New $20M Direct Offering
Tonix Pharmaceuticals has secured approximately $20 million in gross proceeds through a direct offering to Point72, selling 615,025 common...
Tonix Reveals New Hope for Seasonal Lyme Disease Prevention
Tonix Pharmaceuticals has outlined a 2026 FDA engagement to shape a Phase 2/3 path for TNX-4800, a long-acting monoclonal...
Transcenta Collaboration to Advance Affordable Biomanufacturing
Transcenta has entered a strategic collaboration and non-exclusive licensing agreement with EirGenix to deploy Transcenta’s Highly Intensified Continuous Bioprocessing...